ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
Public ClinicalTrials.gov record NCT05907096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function
Study identification
- NCT ID
- NCT05907096
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- argenx
- Industry
- Enrollment
- 103 participants
Conditions and interventions
Conditions
Interventions
- ARGX-117 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 16, 2024
- Primary completion
- Oct 15, 2025
- Completion
- Jul 30, 2026
- Last update posted
- Mar 17, 2026
2024 – 2026
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| University of Illinois (UI) Health - Outpatient Care Center | Chicago | Illinois | 60612 | — |
| Cooperman Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Erie County Medical Center | Buffalo | New York | 14215 | — |
| Columbia University | New York | New York | 10032 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 10267 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05907096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05907096 live on ClinicalTrials.gov.